3layout original Article dr Anita suryo



tải về 251.28 Kb.
Chế độ xem pdf
trang3/8
Chuyển đổi dữ liệu26.01.2024
Kích251.28 Kb.
#56472
1   2   3   4   5   6   7   8
1336-2923-1-PB
ehx393 ESC 2017 Ibanez
3. Results
A number of 795 patients were recorded in the Saiful Anwar 
General Hospital ACS registry in between 2018-2021 with 568 subjects 
were enrolled in the study. Between selected subjects, 387 patients had 
received early PPCI, 107 patients had received late PPCI, while 74 
patients had received optimal medical therapy, i.e. did not receive PPCI 
and/or fibrinolytic. Percentage comparison between each category was 
shown in Figure 3.1.
The data showed significant reduction in the percentage of 
patients receiving early PPCI during 4 years timeframe, with 73.8% 
patients received early PPCI in 2018 and 56.8% patients received early 
PPCI in 2021. On the contrary, patients receiving late PPCI has substan-
tially increased from 15.9% in 2018 and 30.7% in 2021 with significant 
rise occurred in the last two years. Patients receiving optimal medical 
therapy however, have been relatively steady in the past 4 years.
3.1 Baseline Characteristic Comparison
The percentage of subjects represented in baseline character-
istics such as gender, age, and body weight was proportionally distrib-
uted in between each category. Significant results regarding onset 
within each category was also demonstrated (P=0.01). There were also 
no significant difference in between the percentage of cardiovascular 
risk factors i.e. smoking, diabetes, hypertension, dyslipidemia, family 
history of CAD, etc. within each category as shown in table 3.1. Howev-
er, the proportion of patients presenting with KILLIP Class IV was 
substantially higher within optimal medical therapy category compared 
with late and early PPCI group (P=0.049). This result was also consis-
tent with higher GRACE score (P=0.001) and Troponin I levels 
(P=0.043) in patients receiving optimal medical therapy. While other 
baseline parameters were evenly measured in between each category.
Figure 3.1 Comparison of patients in each category from 2018-2021


A. S. Santoso, et al.
Heart Sci J 2022; 3(2): 10-17
12
Table 3.2 Baseline characteristics of subjects in each category

tải về 251.28 Kb.

Chia sẻ với bạn bè của bạn:
1   2   3   4   5   6   7   8




Cơ sở dữ liệu được bảo vệ bởi bản quyền ©hocday.com 2024
được sử dụng cho việc quản lý

    Quê hương